These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias. Stewart DE; Ikram H N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758 [TBL] [Abstract][Full Text] [Related]
10. Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation. Kubara I; Ikeda H; Hiraki T; Yoshida T; Ohga M; Imaizumi T J Cardiovasc Electrophysiol; 1999 May; 10(5):670-9. PubMed ID: 10355923 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravenous disopyramide in acute cardiac arrhythmias. De Backer M; Stoupel E; Kahn RJ Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824 [TBL] [Abstract][Full Text] [Related]
12. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers]. Romero-Ayala LC; SonĂ J Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095 [TBL] [Abstract][Full Text] [Related]
13. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. Bennett DH Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119 [TBL] [Abstract][Full Text] [Related]
14. [Intravenously disopyramide phosphate administration for treatment of arrhythmias]. Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147 [TBL] [Abstract][Full Text] [Related]
15. The antiarrhythmic effect of intravenous disopyramide in an open study. Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238 [TBL] [Abstract][Full Text] [Related]
16. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)]. Smith WS Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients. Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034 [TBL] [Abstract][Full Text] [Related]
18. Atrial tachyarrhythmias after cardiac surgery: results of disopyramide therapy. Gavaghan TP; Feneley MP; Campbell TJ; Morgan JJ Aust N Z J Med; 1985 Feb; 15(1):27-32. PubMed ID: 3859260 [TBL] [Abstract][Full Text] [Related]
19. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Chimienti M; Cullen MT; Casadei G Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031 [TBL] [Abstract][Full Text] [Related]
20. [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. Piot O; Flammang D; Dambrine P; Cheikel J; Jouannon C; Graux P; Baudouy Y; Bine-Scheck F; Leenhardt A Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1481-6. PubMed ID: 9891831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]